Literature DB >> 17156873

Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.

Carsten Nieder1, Sabine Schill, Peter Kneschaurek, Michael Molls.   

Abstract

BACKGROUND AND
PURPOSE: To study different radiotherapy techniques for female patients with mediastinal target volumes. Especially in highly curable diseases such as lymphoma, long-term survivors might develop late cardiac damage and radiation-induced second cancer. PATIENTS AND METHODS: Planning CT scans were obtained in eight cases. We contoured the clinical target volume (three different scenarios with or without lower mediastinum and hili) and organs at risk and compared standard 6MV ap-pa opposed fields to a 3D conformal 4-field technique and a 7-field step-and-shoot IMRT technique and evaluated DVHs for each structure. The planning system was BrainSCAN 5.21 (BrainLAB, Heimstetten, Germany).
RESULTS: Target volume coverage did not improve significantly with 4-field or IMRT techniques. However, IMRT resulted in better dose reduction to the heart than the other techniques. The median heart dose (intermediately sized target volume) was 98% (95-100) with ap-pa fields, 56% (52-79) with the 4-field technique, and 39% (36-65) with IMRT, for example (p<0.05). Better heart sparing was achieved at all dose levels down to the 15% isodose. The median maximum dose to the breasts was lowest with IMRT. The breast volume receiving low doses (15% or less), however, was highest with IMRT. There was also a disadvantage in mean lung dose.
CONCLUSIONS: IMRT might result in a reduced cardiac complication risk. In younger females, however, this advantage might be offset by the risk of breast cancer. The best technique for a given patient depends on age, comorbidity, and the individual risk estimates for breast cancer and cardiac morbidity, respectively.

Entities:  

Mesh:

Year:  2006        PMID: 17156873     DOI: 10.1016/j.radonc.2006.10.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.

Authors:  Jan Kriz; Max Spickermann; Philipp Lehrich; Heinz Schmidberger; Gabriele Reinartz; Hans Eich; Uwe Haverkamp
Journal:  Strahlenther Onkol       Date:  2015-04-16       Impact factor: 3.621

2.  [Risk of heart failure in patients with Hodgkin lymphoma after radiation and anthracycline chemotherapy].

Authors:  J Kriz; H T Eich
Journal:  Strahlenther Onkol       Date:  2017-08       Impact factor: 3.621

Review 3.  Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

Authors:  Stephanie A Terezakis; Yvette L Kasamon
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-29       Impact factor: 6.312

4.  Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Authors:  Tomohiro Aoki; Koji Izutsu; Ritsuro Suzuki; Chiaki Nakaseko; Hiroshi Arima; Kazuyuki Shimada; Akihiro Tomita; Makoto Sasaki; Jun Takizawa; Kinuko Mitani; Tadahiko Igarashi; Yoshinobu Maeda; Noriko Fukuhara; Fumihiro Ishida; Nozomi Niitsu; Ken Ohmachi; Hirotaka Takasaki; Naoya Nakamura; Tomohiro Kinoshita; Shigeo Nakamura; Michinori Ogura
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

Review 5.  Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.

Authors:  Andrea Riccardo Filippi; Sofia Meregalli; Anna DI Russo; Mario Levis; Patrizia Ciammella; Michela Buglione; Andrea Emanuele Guerini; Giuseppina De Marco; Vitaliana De Sanctis; Stefano Vagge; Umberto Ricardi; Gabriele Simontacchi
Journal:  Radiat Oncol       Date:  2020-03-12       Impact factor: 3.481

6.  Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?

Authors:  Vitaliana De Sanctis; Chiara Bolzan; Marco D'Arienzo; Stefano Bracci; Alessandro Fanelli; Maria Christina Cox; Maurizio Valeriani; Mattia F Osti; Giuseppe Minniti; Laura Chiacchiararelli; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2012-08-02       Impact factor: 3.481

7.  Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.

Authors:  Laura Cella; Manuel Conson; Maria Cristina Pressello; Silvia Molinelli; Uwe Schneider; Vittorio Donato; Roberto Orecchia; Marco Salvatore; Roberto Pacelli
Journal:  Radiat Oncol       Date:  2013-01-30       Impact factor: 3.481

8.  Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerations.

Authors:  Christian Fiandra; Andrea Riccardo Filippi; Paola Catuzzo; Angela Botticella; Patrizia Ciammella; Pierfrancesco Franco; Valeria Casanova Borca; Riccardo Ragona; Santi Tofani; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2012-11-02       Impact factor: 3.481

9.  Influence of different treatment techniques on radiation dose to the LAD coronary artery.

Authors:  Carsten Nieder; Sabine Schill; Peter Kneschaurek; Michael Molls
Journal:  Radiat Oncol       Date:  2007-06-05       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.